Mr. Chairman, I heard earlier from another Member that we were going to attempt to inject a little reality into the debate. The preceding attempt was in vain, so let me do it for us assembled here tonight. My colleagues, there are differences of opinion honestly held. But I would caution us all not to become so obsessed with process that we fail to deal with the issue at hand. The reality is the gentleman from Washington has offered an amendment that I think is all together proper and one that we should all support because it adds greatly needed funds in an area where the need is acute: $24 million for the--I am sorry, $2 million--$22 million, forgive me, I stand corrected, and I thank my colleagues for that really unprecedented bipartisan cooperation to get the numbers right here tonight, $22 million to help Americans who have been ravaged by a horrible disease. That is the question. Not the other process, not the alleged road map of intrigue. This is the simple question, an up or down question on helping these Americans.
NAN A. S. HAYWORTH: “Mr. Chairman, I heard earlier from another Member that we were going to attempt to inject a little reality into the…”
Editor's note · Context
Addressing the need for funding to support Americans affected by a disease during a House debate.
Share
More from NAN A. S. HAYWORTH
I have introduced legislation, in fact it passed unanimously through our subcommittee and committee, to repeal most of the swaps push-out, Section 716 of Dodd-Frank.
if my friend would yield briefly, I just wanted to return to the floor first of all to thank my colleague from Texas and to state what is obvious to his constituents. He brings a dedication and a passion to this Congress in his first term…
my colleagues, here we are in America's House, having a debate that is altogether appropriate, because as our founders stated the goal, it was to form a more perfect union. And because we are human beings, there is always a gulf between…
Clearly we need that kind of quantitative analysis, because obviously we have to assess the costs and benefits of what we are doing.





